The therapeutic potential of modulating the ceramide/sphingomyelin pathway
- PMID: 12093880
- PMCID: PMC151041
- DOI: 10.1172/JCI16127
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Figures
Similar articles
-
Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress.Methods Cell Biol. 2001;66:135-65. doi: 10.1016/s0091-679x(01)66007-2. Methods Cell Biol. 2001. PMID: 11396001 No abstract available.
-
Ceramide in apoptosis: an overview and current perspectives.Biochim Biophys Acta. 2002 Dec 30;1585(2-3):114-25. doi: 10.1016/s1388-1981(02)00331-1. Biochim Biophys Acta. 2002. PMID: 12531544 Review.
-
Sphingolipid metabolism in the regulation of bioactive molecules.Lipids. 1999;34 Suppl:S5-11. doi: 10.1007/BF02562221. Lipids. 1999. PMID: 10419081 Review. No abstract available.
-
Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver.Prostaglandins Other Lipid Mediat. 2007 Jun;83(4):277-84. doi: 10.1016/j.prostaglandins.2007.02.001. Epub 2007 Feb 11. Prostaglandins Other Lipid Mediat. 2007. PMID: 17499747
-
Sphingomyelin metabolism is developmentally regulated in rat lung.Am J Respir Cell Mol Biol. 1997 May;16(5):605-12. doi: 10.1165/ajrcmb.16.5.9160843. Am J Respir Cell Mol Biol. 1997. PMID: 9160843
Cited by
-
C24:0 and C24:1 sphingolipids in cholesterol-containing, five- and six-component lipid membranes.Sci Rep. 2020 Aug 24;10(1):14085. doi: 10.1038/s41598-020-71008-8. Sci Rep. 2020. PMID: 32839481 Free PMC article.
-
Ceramide function in the brain: when a slight tilt is enough.Cell Mol Life Sci. 2013 Jan;70(2):181-203. doi: 10.1007/s00018-012-1038-x. Epub 2012 Jun 24. Cell Mol Life Sci. 2013. PMID: 22729185 Free PMC article. Review.
-
Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.Diabetes. 2006 Dec;55(12):3573-80. doi: 10.2337/db06-0539. Diabetes. 2006. PMID: 17130506 Free PMC article.
-
Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP.Glycoconj J. 2004;20(3):157-68. doi: 10.1023/B:GLYC.0000024254.64450.8b. Glycoconj J. 2004. PMID: 15090729
-
Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Expert Opin Ther Targets. 2010 May;14(5):529-39. doi: 10.1517/14728221003752768. Expert Opin Ther Targets. 2010. PMID: 20334489 Free PMC article. Review.
References
-
- Kolesnick RN. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res. 1991;30:1–38. - PubMed
-
- Kolesnick RN. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3pituitary cells. J Biol Chem. 1987;262:16759–16762. - PubMed
-
- Kolesnick RN, Clegg S. 1,2-Diacylglycerols, but not phorbol esters, activate a potential inhibitory pathway for protein kinase C in GH3pituitary cells: evidence for involvement of a sphingomyelinase. J Biol Chem. 1988;263:6534–6537. - PubMed
-
- Kolesnick RN. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. J Biol Chem. 1989;264:7617–7623. - PubMed
-
- Okazaki T, Bell RM, Hannun Y. Sphingomyelin turnover induced by vitamin D3in HL-60 cells: role in cell differentiation. J Biol Chem. 1989;264:19076–19080. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources